JP2024037864A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2024037864A5 JP2024037864A5 JP2023209915A JP2023209915A JP2024037864A5 JP 2024037864 A5 JP2024037864 A5 JP 2024037864A5 JP 2023209915 A JP2023209915 A JP 2023209915A JP 2023209915 A JP2023209915 A JP 2023209915A JP 2024037864 A5 JP2024037864 A5 JP 2024037864A5
- Authority
- JP
- Japan
- Prior art keywords
- cells
- human
- rpe
- rpe cells
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025120956A JP2025161815A (ja) | 2011-11-14 | 2025-07-18 | ヒトｒｐｅ細胞医薬品およびその使用 |
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161559521P | 2011-11-14 | 2011-11-14 | |
| US61/559,521 | 2011-11-14 | ||
| US201261589741P | 2012-01-23 | 2012-01-23 | |
| US61/589,741 | 2012-01-23 | ||
| US201261724047P | 2012-11-08 | 2012-11-08 | |
| US61/724,047 | 2012-11-08 | ||
| JP2019098508A JP6899865B2 (ja) | 2011-11-14 | 2019-05-27 | ヒトｒｐｅ細胞医薬品およびその使用 |
| JP2021049493A JP7081016B2 (ja) | 2011-11-14 | 2021-03-24 | ヒトｒｐｅ細胞医薬品およびその使用 |
| JP2022084915A JP7404441B2 (ja) | 2011-11-14 | 2022-05-25 | ヒトｒｐｅ細胞医薬品およびその使用 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022084915A Division JP7404441B2 (ja) | 2011-11-14 | 2022-05-25 | ヒトｒｐｅ細胞医薬品およびその使用 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025120956A Division JP2025161815A (ja) | 2011-11-14 | 2025-07-18 | ヒトｒｐｅ細胞医薬品およびその使用 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024037864A JP2024037864A (ja) | 2024-03-19 |
| JP2024037864A5 true JP2024037864A5 (enExample) | 2024-08-22 |
| JP7716463B2 JP7716463B2 (ja) | 2025-07-31 |
Family
ID=47470610
Family Applications (7)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014541421A Active JP6506023B2 (ja) | 2011-11-14 | 2012-11-14 | ヒトｒｐｅ細胞医薬品およびその使用 |
| JP2017183914A Active JP6563996B2 (ja) | 2011-11-14 | 2017-09-25 | ヒトｒｐｅ細胞医薬品およびその使用 |
| JP2019098508A Active JP6899865B2 (ja) | 2011-11-14 | 2019-05-27 | ヒトｒｐｅ細胞医薬品およびその使用 |
| JP2021049493A Active JP7081016B2 (ja) | 2011-11-14 | 2021-03-24 | ヒトｒｐｅ細胞医薬品およびその使用 |
| JP2022084915A Active JP7404441B2 (ja) | 2011-11-14 | 2022-05-25 | ヒトｒｐｅ細胞医薬品およびその使用 |
| JP2023209915A Active JP7716463B2 (ja) | 2011-11-14 | 2023-12-13 | ヒトｒｐｅ細胞医薬品およびその使用 |
| JP2025120956A Pending JP2025161815A (ja) | 2011-11-14 | 2025-07-18 | ヒトｒｐｅ細胞医薬品およびその使用 |
Family Applications Before (5)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014541421A Active JP6506023B2 (ja) | 2011-11-14 | 2012-11-14 | ヒトｒｐｅ細胞医薬品およびその使用 |
| JP2017183914A Active JP6563996B2 (ja) | 2011-11-14 | 2017-09-25 | ヒトｒｐｅ細胞医薬品およびその使用 |
| JP2019098508A Active JP6899865B2 (ja) | 2011-11-14 | 2019-05-27 | ヒトｒｐｅ細胞医薬品およびその使用 |
| JP2021049493A Active JP7081016B2 (ja) | 2011-11-14 | 2021-03-24 | ヒトｒｐｅ細胞医薬品およびその使用 |
| JP2022084915A Active JP7404441B2 (ja) | 2011-11-14 | 2022-05-25 | ヒトｒｐｅ細胞医薬品およびその使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025120956A Pending JP2025161815A (ja) | 2011-11-14 | 2025-07-18 | ヒトｒｐｅ細胞医薬品およびその使用 |
Country Status (23)
| Country | Link |
|---|---|
| US (4) | US20130195806A1 (enExample) |
| EP (2) | EP3563860A1 (enExample) |
| JP (7) | JP6506023B2 (enExample) |
| KR (1) | KR102054904B1 (enExample) |
| CN (2) | CN113786417A (enExample) |
| AU (5) | AU2012340020A1 (enExample) |
| CA (2) | CA2855941A1 (enExample) |
| CY (1) | CY1121819T1 (enExample) |
| DK (1) | DK2780022T4 (enExample) |
| ES (1) | ES2734453T3 (enExample) |
| FI (1) | FI2780022T4 (enExample) |
| GB (1) | GB2496969A (enExample) |
| HK (1) | HK1202456A1 (enExample) |
| HR (1) | HRP20191110T1 (enExample) |
| HU (1) | HUE044778T2 (enExample) |
| IL (5) | IL287381B2 (enExample) |
| LT (1) | LT2780022T (enExample) |
| PL (1) | PL2780022T3 (enExample) |
| PT (1) | PT2780022T (enExample) |
| RS (1) | RS59050B1 (enExample) |
| SI (1) | SI2780022T1 (enExample) |
| TW (5) | TW202434266A (enExample) |
| WO (1) | WO2013074681A1 (enExample) |
Families Citing this family (69)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7794704B2 (en) | 2004-01-23 | 2010-09-14 | Advanced Cell Technology, Inc. | Methods for producing enriched populations of human retinal pigment epithelium cells for treatment of retinal degeneration |
| SG188122A1 (en) | 2004-01-23 | 2013-03-28 | Advanced Cell Tech Inc | Improved modalities for the treatment of degenerative diseases of the retina |
| ES2764473T3 (es) | 2007-10-12 | 2020-06-03 | Astellas Inst For Regenerative Medicine | Métodos mejorados para producir células RPE y composiciones de células RPE |
| WO2011063005A2 (en) | 2009-11-17 | 2011-05-26 | Advanced Cell Technology, Inc. | Methods of producing human rpe cells and pharmaceutical preparations of human rpe cells |
| US10852069B2 (en) | 2010-05-04 | 2020-12-01 | Fractal Heatsink Technologies, LLC | System and method for maintaining efficiency of a fractal heat sink |
| ES2874953T3 (es) | 2010-07-23 | 2021-11-05 | Astellas Inst For Regenerative Medicine | Métodos para la detección de subpoblaciones raras de células y composiciones muy purificadas de células |
| US11021733B2 (en) | 2011-09-26 | 2021-06-01 | Qiagen Gmbh | Stabilization and isolation of extracellular nucleic acids |
| AU2012314514B2 (en) | 2011-09-26 | 2018-03-15 | Qiagen Gmbh | Stabilisation and isolation of extracellular nucleic acids |
| ES2574956T3 (es) | 2011-09-26 | 2016-06-23 | Preanalytix Gmbh | Estabilización y aislamiento de ácidos nucleicos extracelulares |
| CA2855941A1 (en) * | 2011-11-14 | 2013-05-23 | Advanced Cell Technology, Inc. | Pharmaceutical preparations of human rpe cells and uses thereof |
| CA2884915C (en) | 2012-09-25 | 2022-05-17 | Qiagen Gmbh | Stabilisation of biological samples |
| US20150368713A1 (en) | 2013-02-01 | 2015-12-24 | THE UNITED STATES OF AMERICAN, as represented by the Secretary, Department of Health and Human Serv | METHOD FOR GENERATING RETINAL PIGMENT EPITHELIUM (RPE) CELLS FROM INDUCED PLURIPOTENT STEM CELLS (IPSCs) |
| WO2014146780A1 (en) | 2013-03-18 | 2014-09-25 | Qiagen Gmbh | Stabilization and isolation of extracellular nucleic acids |
| EP3447141B1 (en) | 2013-03-18 | 2020-08-05 | PreAnalytiX GmbH | Stabilisation of biological samples |
| RU2704984C1 (ru) | 2013-11-27 | 2019-11-01 | Киото Прифекчурал Паблик Юниверсити Корпорэйшн | Применение ламинина в культуре клеток эндотелия роговицы |
| EP3080248A1 (en) | 2013-12-11 | 2016-10-19 | Pfizer Limited | Method for producing retinal pigment epithelial cells |
| CN106102766A (zh) * | 2014-01-22 | 2016-11-09 | 皮埃尔与玛丽·居里大学 - 巴黎第六大学 | 用于治疗视网膜炎症的试剂 |
| EP2898896A1 (en) * | 2014-01-22 | 2015-07-29 | Université Pierre et Marie Curie (Paris 6) | Agents for use in the treatment of retinal inflammation |
| US20160374330A1 (en) * | 2014-03-18 | 2016-12-29 | Qiagen Gmbh | Stabilization and isolation of extracellular nucleic acids |
| WO2015175504A1 (en) * | 2014-05-12 | 2015-11-19 | The Johns Hopkins University | Differentiation of human pluripotent stem cells into retinal pigment epithelium using hif1 inhibitors |
| US10457915B2 (en) | 2014-05-15 | 2019-10-29 | International Stem Cell Corporation | Chemical differentiation of pluripotentstem cells into retinal epithelial cells |
| US10597633B2 (en) | 2014-05-16 | 2020-03-24 | Koninklijke Nederlandse Akademie Van Wetenschappen | Culture method for organoids |
| US9840553B2 (en) | 2014-06-28 | 2017-12-12 | Kodiak Sciences Inc. | Dual PDGF/VEGF antagonists |
| US20160095307A1 (en) | 2014-10-07 | 2016-04-07 | NuTech Medical, Inc. | Method and composition for hypothermic storage of placental tissue |
| JP6849590B2 (ja) | 2014-10-17 | 2021-03-24 | コディアック サイエンシーズ インコーポレイテッドＫｏｄｉａｋ Ｓｃｉｅｎｃｅｓ Ｉｎｃ． | ブチリルコリンエステラーゼ両性イオン性ポリマーコンジュゲート |
| WO2016067629A1 (ja) * | 2014-10-31 | 2016-05-06 | 京都府公立大学法人 | ラミニンによる網膜および神経の新規治療 |
| CN113559246A (zh) * | 2014-10-31 | 2021-10-29 | 京都府公立大学法人 | 使用层粘连蛋白的新的角膜的治疗 |
| KR102728629B1 (ko) * | 2014-12-18 | 2024-11-12 | 쏘흐본느 유니베흐시테 | 망막 변성의 치료를 위한 otx2를 과발현하는 형질전환 rpe 세포 |
| MX2017008737A (es) * | 2014-12-30 | 2018-01-25 | Cell Cure Neurosciences Ltd | Poblaciones de celulas rpe y metodos para generar las mismas. |
| EA201791518A1 (ru) * | 2014-12-30 | 2017-10-31 | Селл Кьюр Нейросайансес Лтд. | Способы лечения заболеваний сетчатки |
| US20180011092A1 (en) | 2014-12-30 | 2018-01-11 | Cell Cure Neurosciences Ltd. | Assessing retinal pigment epithelial cell populations |
| EP4343331A3 (en) * | 2015-03-23 | 2024-06-19 | Astellas Institute for Regenerative Medicine | Improved assays for potency of human retinal pigment epithelium (rpe) cells and photoreceptor progenitors |
| CN105013010B (zh) * | 2015-07-07 | 2018-01-12 | 中山大学中山眼科中心 | 一种辅助iPS‑RPE移植的层粘连蛋白膜 |
| PL3331994T3 (pl) | 2015-08-05 | 2023-01-30 | Cell Cure Neurosciences Ltd. | Wytwarzanie komórek nabłonka barwnikowego siatkówki |
| AU2016308818B2 (en) | 2015-08-18 | 2022-04-21 | Astellas Institute For Regenerative Medicine | Clinical formulations |
| AU2016318774B2 (en) * | 2015-09-08 | 2022-08-18 | FUJIFILM Cellular Dynamics, Inc. | MACS-based purification of stem cell-derived retinal pigment epithelium |
| CA3005694A1 (en) | 2015-11-20 | 2017-05-26 | Qiagen Gmbh | Method of preparing sterilized compositions for stabilization of extracellular nucleic acids |
| WO2017117464A1 (en) | 2015-12-30 | 2017-07-06 | Kodiak Sciences Inc. | Antibodies and conjugates thereof |
| GB201603569D0 (en) | 2016-03-01 | 2016-04-13 | Koninklijke Nederlandse Akademie Van Wetenschappen | Improved differentiation method |
| CN106420809B (zh) * | 2016-08-31 | 2017-08-08 | 浙江济民制药股份有限公司 | 一种眼科手术灌注液 |
| EP3555266B1 (en) * | 2016-12-13 | 2023-11-15 | The United States of America, as Represented by The Secretary, Department of Health and Human Services | Methods of preparing an isolated or purified population of thymic emigrant cells and methods of treatment using same |
| EP3824906A1 (en) | 2016-12-21 | 2021-05-26 | Amgen Inc. | Anti-tnf alpha antibody formulations |
| US11076984B2 (en) * | 2017-03-13 | 2021-08-03 | Gyroscope Therapeutics Limited | Method of performing subretinal drainage and agent delivery |
| CN110913874A (zh) * | 2017-03-16 | 2020-03-24 | 谱系细胞疗法公司 | 用于测量视网膜疾病疗法的疗效的方法 |
| AU2018263853A1 (en) * | 2017-05-01 | 2019-11-14 | The Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College | Compositions and methods for treating ocular pathologies |
| SG11202005795TA (en) * | 2017-12-29 | 2020-07-29 | Cell Cure Neurosciences Ltd | Retinal pigment epithelium cell compositions |
| EP4371535A3 (en) | 2018-02-22 | 2024-08-14 | Alcon Inc. | Ocular implant |
| BR112020017872A2 (pt) * | 2018-03-02 | 2020-12-22 | Kodiak Sciences Inc. | Anticorpos de il-6 e construtos de fusão e conjugados dos mesmos |
| KR20210095885A (ko) * | 2018-11-19 | 2021-08-03 | 더 유나이티드 스테이츠 오브 어메리카, 애즈 리프리젠티드 바이 더 세크러테리, 디파트먼트 오브 헬쓰 앤드 휴먼 서비씨즈 | 생분해성 조직 대체 임플란트 및 그의 용도 |
| JP7590968B2 (ja) * | 2018-12-05 | 2024-11-27 | アビオナ・セラピュ―ティクス・インコーポレイテッド | 遺伝子送達のための組み換えアデノ随伴ウイルスベクター |
| JP7701879B2 (ja) * | 2019-05-28 | 2025-07-02 | エフ． ホフマン－ラ ロシュ アーゲー | 単球前駆細胞を生成するための方法 |
| KR102198942B1 (ko) * | 2019-07-02 | 2021-01-05 | 의료법인 성광의료재단 | Pedf를 발현하거나 모세포에 비하여 pedf를 과발현하도록 유전적으로 조작된 중간엽 줄기세포 |
| WO2021034784A1 (en) | 2019-08-16 | 2021-02-25 | Poltorak Technologies, LLC | Device and method for medical diagnostics |
| WO2021072265A1 (en) | 2019-10-10 | 2021-04-15 | Kodiak Sciences Inc. | Methods of treating an eye disorder |
| MX2022005134A (es) | 2019-10-30 | 2022-05-30 | Astellas Inst For Regenerative Medicine | Metodos para producir celulas del epitelio pigmentario retiniano. |
| CA3161672A1 (en) * | 2019-11-22 | 2021-05-27 | Sigilon Therapeutics, Inc. | Monoclonal cell lines expressing an exogenous substance and uses thereof |
| KR20220130125A (ko) | 2020-01-21 | 2022-09-26 | 다케다 야쿠힌 고교 가부시키가이샤 | 동결보존 세포의 조성물 및 방법 |
| KR20220150906A (ko) * | 2020-02-07 | 2022-11-11 | 더 트러스티스 오브 컬럼비아 유니버시티 인 더 시티 오브 뉴욕 | 신경변성의 발병 지연 또는 치료를 위한 대사체의 재프로그래밍 |
| TW202216158A (zh) * | 2020-07-10 | 2022-05-01 | 國立研究開發法人理化學研究所 | 網膜色素上皮細胞之移植用存活促進劑 |
| CN112544612A (zh) * | 2020-12-18 | 2021-03-26 | 江苏艾尔康生物医药科技有限公司 | 冻存液及其在rpe细胞冻存中的应用 |
| CN112834411B (zh) * | 2021-01-07 | 2022-05-27 | 上海交通大学 | 应用于质谱流式技术的金属纳米探针及制备方法和应用 |
| CN112926116B (zh) * | 2021-03-01 | 2023-02-17 | 哈尔滨工业大学 | 一种基于虚拟现实的体育馆火灾疏散行为数据收集系统及其收集方法 |
| CN114246938A (zh) * | 2022-01-25 | 2022-03-29 | 中山大学中山眼科中心 | Il-4在制备用于治疗视网膜变性疾病药物中的应用 |
| WO2023149420A1 (ja) * | 2022-02-01 | 2023-08-10 | 株式会社坪田ラボ | 近視を予防または治療するための方法および組成物 |
| CN114561356B (zh) * | 2022-03-09 | 2022-09-13 | 北京呈诺医学科技有限公司 | 影响细胞因子分泌的方法及应用 |
| US20250188412A1 (en) * | 2022-03-16 | 2025-06-12 | Sumitomo Pharma Co., Ltd. | Transplantation medium |
| WO2024218311A1 (fr) * | 2023-04-21 | 2024-10-24 | Pulsesight Therapeutics | Compositions à base de décorine pour la réparation et la régéneration de l'épithélium pigmentaire de la rétine |
| WO2024233368A1 (en) * | 2023-05-05 | 2024-11-14 | The Regents Of The University Of California | Retinal pigment epithelium cell therapy |
| CN117625536B (zh) * | 2024-01-26 | 2024-04-30 | 中国人民解放军总医院第三医学中心 | 一种人视网膜色素上皮细胞的纯化、培养方法 |
Family Cites Families (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4138205A (en) | 1975-12-15 | 1979-02-06 | Hydro Pulse Corporation | Movable stator walls permitting access to tubing in peristaltic pump |
| US5610753A (en) | 1991-12-12 | 1997-03-11 | Eastman Kodak Company | Optical design of laser scanner to reduce thermal sensitivity |
| GB9608145D0 (en) * | 1996-04-19 | 1996-06-26 | British Tech Group | Wound healing |
| US20040086494A1 (en) * | 1996-10-07 | 2004-05-06 | John Constance Mary | Immune privileged cells for delivery of proteins and peptides |
| US5998423A (en) | 1996-10-08 | 1999-12-07 | Therasys, Inc. | Methods for modulating melanin production |
| AU9040098A (en) | 1997-09-10 | 1999-03-29 | University Of Florida | Compounds and method for the prevention and treatment of diabetic retinopathy |
| WO1999034834A1 (en) * | 1998-01-02 | 1999-07-15 | Titan Pharmaceuticals, Inc. | Use of pigmented retinal epithelial cells for creation of an immune privilege site |
| US7410798B2 (en) | 2001-01-10 | 2008-08-12 | Geron Corporation | Culture system for rapid expansion of human embryonic stem cells |
| US6943153B1 (en) | 1999-03-15 | 2005-09-13 | The Regents Of The University Of California | Use of recombinant gene delivery vectors for treating or preventing diseases of the eye |
| US6331313B1 (en) | 1999-10-22 | 2001-12-18 | Oculex Pharmaceticals, Inc. | Controlled-release biocompatible ocular drug delivery implant devices and methods |
| US6576422B1 (en) * | 2000-10-17 | 2003-06-10 | Rohm And Haas Company | Method for identifying products employing gene expression |
| US6699493B2 (en) | 2000-11-29 | 2004-03-02 | Oculex Pharmaceuticals, Inc. | Method for reducing or preventing transplant rejection in the eye and intraocular implants for use therefor |
| US20020192738A1 (en) * | 2001-04-27 | 2002-12-19 | Janice Brissette | Tyrosinase assay |
| CA2455499C (en) * | 2001-08-08 | 2011-06-21 | The Trustees Of The University Of Pennsylvania | Method for purification of viral vectors having proteins which bind sialic acid |
| WO2003046141A2 (en) | 2001-11-26 | 2003-06-05 | Advanced Cell Technology, Inc. | Methods for making and using reprogrammed human somatic cell nuclei and autologous and isogenic human stem cells |
| WO2003060083A2 (en) | 2002-01-15 | 2003-07-24 | Advanced Cell Technology, Inc. | Cloning b and t lymphocytes |
| US20040091936A1 (en) | 2002-05-24 | 2004-05-13 | Michael West | Bank of stem cells for producing cells for transplantation having HLA antigens matching those of transplant recipients, and methods for making and using such a stem cell bank |
| US7803750B2 (en) | 2002-07-29 | 2010-09-28 | Duke University | Method of modulating melanin production |
| US7794704B2 (en) | 2004-01-23 | 2010-09-14 | Advanced Cell Technology, Inc. | Methods for producing enriched populations of human retinal pigment epithelium cells for treatment of retinal degeneration |
| SG188122A1 (en) * | 2004-01-23 | 2013-03-28 | Advanced Cell Tech Inc | Improved modalities for the treatment of degenerative diseases of the retina |
| US7309487B2 (en) * | 2004-02-09 | 2007-12-18 | George Inana | Methods and compositions for detecting and treating retinal diseases |
| CA3015835A1 (en) | 2004-11-04 | 2006-05-18 | Astellas Institute For Regenerative Medicine | Derivation of embryonic stem cells |
| US7893315B2 (en) | 2004-11-04 | 2011-02-22 | Advanced Cell Technology, Inc. | Derivation of embryonic stem cells and embryo-derived cells |
| ZA200901914B (en) * | 2006-09-22 | 2010-06-30 | Riken | Stem cell culture medium and method |
| ES2764473T3 (es) * | 2007-10-12 | 2020-06-03 | Astellas Inst For Regenerative Medicine | Métodos mejorados para producir células RPE y composiciones de células RPE |
| GB0806746D0 (en) | 2008-04-14 | 2008-05-14 | Ucl Business Plc | Membrane |
| US9173862B2 (en) * | 2008-04-18 | 2015-11-03 | Arizona Board Of Regents, A Body Corporate Of The State Of Arizona, Acting For And On Behalf Of The University Of Arizona | Methods and compositions for treating and identifying compounds to treat age-related macular degeneration |
| WO2011063005A2 (en) * | 2009-11-17 | 2011-05-26 | Advanced Cell Technology, Inc. | Methods of producing human rpe cells and pharmaceutical preparations of human rpe cells |
| ES2874953T3 (es) * | 2010-07-23 | 2021-11-05 | Astellas Inst For Regenerative Medicine | Métodos para la detección de subpoblaciones raras de células y composiciones muy purificadas de células |
| US20110052678A1 (en) * | 2010-11-05 | 2011-03-03 | Shantha Totada R | Method for treating age related macular degeneration |
| US9487752B2 (en) | 2011-03-30 | 2016-11-08 | Cellular Dynamics International, Inc. | Priming of pluripotent stem cells for neural differentiation |
| EP2702135B1 (en) * | 2011-04-29 | 2019-04-17 | University of Southern California | Method of cryopreservation of stem cell-derived retinal pigment epithelial cells on polymeric substrate |
| CA2855941A1 (en) * | 2011-11-14 | 2013-05-23 | Advanced Cell Technology, Inc. | Pharmaceutical preparations of human rpe cells and uses thereof |
| PT3189135T (pt) * | 2014-09-05 | 2021-08-19 | Astellas Inst For Regenerative Medicine | Células ganclionares retinianas e seus progenitores |
-
2012
- 2012-11-14 CA CA2855941A patent/CA2855941A1/en active Pending
- 2012-11-14 TW TW113103167A patent/TW202434266A/zh unknown
- 2012-11-14 HK HK15103225.4A patent/HK1202456A1/xx unknown
- 2012-11-14 WO PCT/US2012/065091 patent/WO2013074681A1/en not_active Ceased
- 2012-11-14 US US13/676,999 patent/US20130195806A1/en not_active Abandoned
- 2012-11-14 CN CN202110854081.1A patent/CN113786417A/zh active Pending
- 2012-11-14 RS RS20190890A patent/RS59050B1/sr unknown
- 2012-11-14 TW TW107102515A patent/TWI719277B/zh active
- 2012-11-14 SI SI201231636T patent/SI2780022T1/sl unknown
- 2012-11-14 HU HUE12848968 patent/HUE044778T2/hu unknown
- 2012-11-14 IL IL287381A patent/IL287381B2/en unknown
- 2012-11-14 FI FIEP12848968.9T patent/FI2780022T4/fi active
- 2012-11-14 CN CN201280066325.9A patent/CN104080464A/zh active Pending
- 2012-11-14 TW TW109136186A patent/TWI785403B/zh active
- 2012-11-14 GB GB1220511.8A patent/GB2496969A/en not_active Withdrawn
- 2012-11-14 PT PT12848968T patent/PT2780022T/pt unknown
- 2012-11-14 EP EP19164689.2A patent/EP3563860A1/en active Pending
- 2012-11-14 IL IL308205A patent/IL308205B2/en unknown
- 2012-11-14 IL IL320536A patent/IL320536A/en unknown
- 2012-11-14 JP JP2014541421A patent/JP6506023B2/ja active Active
- 2012-11-14 EP EP12848968.9A patent/EP2780022B2/en active Active
- 2012-11-14 HR HRP20191110TT patent/HRP20191110T1/hr unknown
- 2012-11-14 CA CA3178098A patent/CA3178098A1/en active Pending
- 2012-11-14 AU AU2012340020A patent/AU2012340020A1/en not_active Abandoned
- 2012-11-14 DK DK12848968.9T patent/DK2780022T4/da active
- 2012-11-14 LT LTEP12848968.9T patent/LT2780022T/lt unknown
- 2012-11-14 TW TW101142511A patent/TWI655286B/zh active
- 2012-11-14 ES ES12848968T patent/ES2734453T3/es active Active
- 2012-11-14 KR KR1020147016228A patent/KR102054904B1/ko not_active Expired - Fee Related
- 2012-11-14 TW TW111133463A patent/TWI842079B/zh active
- 2012-11-14 PL PL12848968T patent/PL2780022T3/pl unknown
-
2014
- 2014-05-13 IL IL232600A patent/IL232600B/en active IP Right Grant
-
2015
- 2015-05-15 US US14/713,108 patent/US20150366915A1/en not_active Abandoned
-
2017
- 2017-09-08 AU AU2017225146A patent/AU2017225146C1/en active Active
- 2017-09-25 JP JP2017183914A patent/JP6563996B2/ja active Active
-
2019
- 2019-02-20 AU AU2019201201A patent/AU2019201201B2/en active Active
- 2019-05-27 JP JP2019098508A patent/JP6899865B2/ja active Active
- 2019-07-09 CY CY20191100720T patent/CY1121819T1/el unknown
-
2020
- 2020-03-05 IL IL273107A patent/IL273107B/en unknown
- 2020-07-13 US US16/927,068 patent/US20200405767A1/en not_active Abandoned
-
2021
- 2021-03-24 JP JP2021049493A patent/JP7081016B2/ja active Active
- 2021-07-06 AU AU2021204719A patent/AU2021204719B2/en active Active
-
2022
- 2022-05-25 JP JP2022084915A patent/JP7404441B2/ja active Active
-
2023
- 2023-12-13 JP JP2023209915A patent/JP7716463B2/ja active Active
-
2024
- 2024-10-10 US US18/911,566 patent/US20250134932A1/en active Pending
-
2025
- 2025-02-21 AU AU2025201277A patent/AU2025201277A1/en active Pending
- 2025-07-18 JP JP2025120956A patent/JP2025161815A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024037864A5 (enExample) | ||
| IL308205B1 (en) | Pharmaceutical preparations of human rpe cells and uses thereof | |
| CN114404450B (zh) | 一种温敏型干细胞外泌体即型凝胶 | |
| WO2024067874A1 (zh) | 一种改性壳聚糖及其在大分子活性成分递送中的应用 | |
| CN101810563B (zh) | 他克莫司眼用在体凝胶制剂及其制备方法 | |
| TW200410699A (en) | Use of ANECORTAVE acetate for the protection of visual acuity in patients with age related macular degeneration | |
| JP2016121163A (ja) | 眼内でのコルチコステロイド使用に伴う眼圧の発生を減少させる方法 | |
| CN111870702B (zh) | 一种纳米眼用药物的制备方法及其应用 | |
| US9636364B2 (en) | Methods for treating ocular contusion and blunt injury and traumatic injury to the optic nerve | |
| WO2020228743A1 (zh) | 干细胞和细胞因子的组合及其在改善精子活力的用途 | |
| WO2023039168A1 (en) | Use of verteporfin to modulate wound healing after an ocular surgical procedure or ocular injury | |
| JP3310994B2 (ja) | アレルギー治療剤 | |
| CN113521309B (zh) | 人肝细胞生长因子基因在湿疹治疗中的应用及微针药械 | |
| Rizzo et al. | Safety results for geographic atrophy associated with age-related macular degeneration using subretinal cord blood platelet-rich plasma | |
| CN102920722A (zh) | 治疗眼底病的眼用制剂 | |
| CN113786380A (zh) | 一种硝酸毛果芸香碱眼用凝胶及其制备方法 | |
| WO2010083636A1 (zh) | 小牛血去蛋白提取物的滴眼液 | |
| WO2025040177A1 (zh) | 一种适用于耳鼓给药的地塞米松磷酸钠冻干组合物及其制备方法 | |
| CN115068407A (zh) | 一种巴瑞克替尼凝胶剂及其制备方法与用途 | |
| KR102860024B1 (ko) | 이나보글리플로진을 포함하는 안질환의 예방 또는 치료용 약학적 조성물 | |
| Yang et al. | Case report: subconjunctival injection with autologous platelet-rich plasma for refractory corneal ulcers in a dog | |
| CN120227379A (zh) | 芦可替尼在治疗年龄相关性黄斑变性中的应用 | |
| Perone et al. | Safety and efficacy of two ocular anesthetic methods for phacoemulsification: Topical anesthesia and viscoanesthesia (VisThesia™) | |
| CN113041262B (zh) | 内胚层干细胞在预防和/或治疗肝脏免疫失调疾病中的应用 | |
| CN103845330A (zh) | 一类降低眼压的化合物及其用途 |